Novel GH001 Aerosol Delivery System (ADS) device: final results of the GH001-HV-106 trial support going from 3 → 1 doses per treatment visitTRD pivotal program — positive initial feedback from FDA, End-of-Phase 2 meeting expected in Q1 2027, initiation shortly afterPPD pivotal program — initiation targeted for H2 2027Vanina Popova, MD, appointed Chief Development Officer — Formerly Clinical Development at J&J, lead author of pivotal Spravato® trial publicationCash, cash equivalents and marketabl
Dr. Popova will lead the clinical development of GH001 as the company advances toward pivotal programs in TRD and PPDBrings more than 20 years of global pharmaceutical R&D experience at Johnson & Johnson across clinical operations, clinical development, regulatory strategy, and neuroscience portfolio leadershipClinical lead in the Spravato® (esketamine) program, where she led TRANSFORM-2, one of the pivotal Phase 3 trials that supported its approval in TRD, and was lead author of the trial publi
GH Research has delivered a powerful share price run in recent years, which puts fresh attention on whether the current market value lines up with the company’s book value. With the stock recently closing at US$20.86, the question is how much of that price is anchored in the balance sheet and how much reflects expectations that sit beyond it. Over the past 3 years, GH Research has gained about 152.5%. This places a lot of weight on whether its book value can support that kind of share price...
Initiate coverage on GH Research: Buy rating as FDA hold lifts for GH001 TRD, Phase 3 in 2026. Click for more on GHRS stock.
Detailed price information for Ibio Inc (IBIO-Q) from The Globe and Mail including charting and trades.
Recently published Postpartum Depression Market Insights report includes a comprehensive understanding of current treatment practices, postpartum depression emerging drugs, market share of individual therapies, and current and forecasted market size from 2022 to 2036, segmented into leading markets [the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan].
This is the newest page. Registered accounts read further back.